Novavax, Inc. (NVAX): Price and Financial Metrics
NVAX Price/Volume Stats
| Current price | $7.00 | 52-week high | $23.86 |
| Prev. close | $7.26 | 52-week low | $3.81 |
| Day low | $6.93 | Volume | 2,798,100 |
| Day high | $7.29 | Avg. volume | 4,286,405 |
| 50-day MA | $8.14 | Dividend yield | N/A |
| 200-day MA | $10.59 | Market Cap | 1.13B |
NVAX Stock Price Chart Interactive Chart >
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Price Returns
| 1-mo | -15.97% |
| 3-mo | -11.73% |
| 6-mo | -43.18% |
| 1-year | N/A |
| 3-year | -90.50% |
| 5-year | -48.45% |
| YTD | -12.94% |
| 2024 | 67.50% |
| 2023 | -53.31% |
| 2022 | -92.81% |
| 2021 | 28.30% |
| 2020 | 2,701.76% |
Continue Researching NVAX
Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...